Last reviewed · How we verify
NCT06270420: SMART
Technological Devices and Home Automation System in Neurological Rehabilitation
NA trial testing Technological Motor Rehabilitation in Neurological Disease in 80 participants. Status unknown.
31 March 2024
Quick facts
| Lead sponsor | IRCCS San Camillo, Venezia, Italy |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 80 |
| Start date | 5 February 2023 |
| Primary completion | 31 March 2024 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Technological Motor Rehabilitation
Conditions studied
- Neurological Disease — all drugs for Neurological Disease →
- Motor Disorders — all drugs for Motor Disorders →
Sponsor
IRCCS San Camillo, Venezia, Italy
Who can join
18 and older, any sex, with Neurological Disease or Motor Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The use of home automation system may be useful in rehabilitation to collect data about the environment and the amount of therapy. Then, the data may be stored in a cloud and integrated with data collected during training provided by technological devices. The main goal of this longitudinal pilot study is to define the productivity of the rehabilitation room (i.e., HoSmartAI room) in the IRCCS San Camillo Hospital (Venice, Italy) service, where the investigators will install home automation sensors and treat patients with neurological disease using technological devices (e.g., robotic and virtual reality). The secondary goals are to define the patients' satisfaction, usability of the system and the clinical effect of treatments delivered with technological devices in the HoSmartAI room. The patient will be assessed to personalized the treatment based on their needs. The treatment will consist of 15 sessions (1h/day, 5day/week, 3 weeks). At the end of the study, the patients will be assessed to define any clinical improvements. Finally, the investigators will define the characteristics of the patients who will benefit from the rehabilitation provided in the HoSmartAI room.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Integration of Smart Home and Building Automation Systems in Virtual Reality and Robotics-Based Technological Environment for Neurorehabilitation: A Pilot Study Protocol.
Federico S, Zitti M, Regazzetti M, Dal Pozzo E, et al · · 2024 · PMID 38793104 · DOI 10.3390/jpm14050522
Verify or expand the search:
- PubMed search for NCT06270420
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurological Disease
Currently open trials in the same condition.
- NCT06235580 — Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions · recruiting
Other IRCCS San Camillo, Venezia, Italy trials
Trials by the same sponsor.
- NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
- NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
- NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
- NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting
- NCT05815368 — Efficacy of REMO Training for Hand Motor Recovery After Stroke · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06270420 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270420.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing